BCRX (US) share price forecast & AI signal — BioCryst Pharmaceuticals, Inc
Week of 2026-10-30 · Healthcare
Exact confidence, 1-week / 1-month / 3-month breakdown, plain-English AI write-up, bull-vs-bear debate, support & resistance.
Get 5 free tokens — no card Already a member? Open the full analysisWhat the model sees in BCRX
BioCryst Pharmaceuticals, Inc is a Healthcare stock listed on the US. For the week of 2026-10-30 the ACE machine-learning model rates it a BUY with low confidence, based on technical indicators and the stock's own historical patterns across three time horizons. The direction is updated every model run.
About BioCryst Pharmaceuticals, Inc
BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated and seasonal influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat HAE. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in phase 1; Avoralstat, an ocular plasma kallikrein inhibitor for diabetic macular edema that is in Phase 1; Navenibart, a monoclonal antibody plasma kallikrein inhibitor for HAE which is in Phase 3;...
Recent closes
| Date | Close |
|---|---|
| 2026-11-06 | $7.69 |
| 2026-11-05 | $7.63 |
| 2026-11-04 | $8.24 |
| 2026-11-03 | $8.57 |
| 2026-11-02 | $8.25 |
| 2026-10-30 | $8.47 |
| 2026-10-29 | $8.52 |
BCRX FAQ
Is BioCryst Pharmaceuticals, Inc (BCRX) a buy or sell this week?
The ACE Stock Bots machine-learning model rates BCRX a BUY for the week of 2026-10-30 with low confidence. The exact confidence and the 1-week, 1-month and 3-month breakdown are free with a signup (5 analysis tokens, no card).
What is the AI share price forecast for BCRX?
Every week the model scores BCRX across three horizons using technical indicators and the stock's own historical patterns. An AI then writes a plain-English summary with support and resistance levels, and a bull analyst and a bear analyst argue the case.
Is this financial advice?
No. ACE Stock Bots provides general information generated by software. It does not consider your objectives, financial situation or needs. Read the disclaimer and consider licensed advice before acting.
Other Healthcare stocks on the US
This week's top US picks · All US stocks
Signals are generated by software for general information only and are not a recommendation to buy or sell. See the disclaimer.